At the end of November, Southern California saw a surge in medical emergencies linked to a bad batch of synthetic marijuana. Commonly sold under the brand name of Spice or K2, synthetic cannabinoid users often experience severe side effects that, without treatment, can be fatal.
On the other side of the country, the State of Florida has seen a dramatic rise in synthetic drug related incidents in recent years. The chemicals used to make these types of drugs are manufactured in China, and then sprayed on herbs or bath salts. When ingested, the chemicals produce a number of effects, such as hallucinations, increased energy, and euphoria.
Use of synthetic drugs has been associated with:
- Suicidal Tendencies and Attempts
- Homicidal Tendencies
- Chest Pain
- Heart attack
Until recently, synthetic drug manufacturers in China operated with little impunity. Producers of the chemicals have no oversight and do not conduct human testing before they sell their chemicals. After serious scrutiny from the United States and others, China banned more than 100 chemicals used to make synthetic drugs, The Miami Herald reports. Chemicals used to make alpha-PVP, better known as flakka, which has been abused all over South Florida as of late. The U.S. Drug Enforcement Administration reports that it is now illegal in China to distribute flakka, fentanyl, and other chemicals at home and overseas.
“The ban of the sale of the listed synthetic drugs will hopefully have a positive impact with regard to reducing the designer drug threat in the United States,” said Diane Boland, director of toxicology at the Miami-Dade Medical Examiner’s Office. “Only time will tell.”
On top the serious side effects produced by synthetic drugs, the substances can become habit forming, leading to addiction. If you or a loved one struggles with synthetic drug use, please contact Synergy Group Services. Our approach is rooted in a holistic mind, body and spirit approach, which blends traditional counseling and alternative medicine to achieve a synergistic outcome.